Tue, 07 Feb 2023

NEW YORK, NY / ACCESSWIRE / January 24, 2023 / Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the 'M&A Class Action Firm'), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:

Albireo Pharma, Inc. (NASDAQ:ALBO), relating to its proposed sale to Ipsen. Under the terms of the agreement, ALBO shareholders are expected to receive $42.00 in cash per share they own, plus one Contingent Value Right worth a deferred $10.00 per share. Click here for more information: https://www.monteverdelaw.com/case/albireo-pharma-inc. It is free and there is no cost or obligation to you.

CinCor Pharma, Inc. (NASDAQ:CINC), relating to its proposed sale to AstraZeneca. Under the terms of the agreement, CINC shareholders are expected to receive $26.00 and one Contingent Value Right worth $10.00 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/cincor-pharma-inc. It is free and there is no cost or obligation to you.

IMARA Inc. (Nasdaq:IMRA), relating to its proposed merger with Enliven Therapeutics, Inc. Under the terms of the agreement, IMRA shareholders are expected to own approximately 16% of the combined company. Click here for more information: https://www.monteverdelaw.com/case/imara-inc. It is free and there is no cost or obligation to you.

Monteverde & Associates PC, Tuesday, January 24, 2023, Press release picture

About Monteverde & Associates PC

We are a national class action securities and consumer litigation law firm that has recovered millions of dollars for shareholders and is committed to protecting investors and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013 and 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2020 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, over the years the firm has recovered or secured over a dozen cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2023 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC



View source version on accesswire.com:
https://www.accesswire.com/736605/STOCKHOLDER-ALERT-The-MA-Class-Action-Firm-Continues-Investigating-the-Merger-ALBO-CINC-IMRA

More Orlando News

Access More

Sign up for The Orlando News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!